FLIP the switch: Regulation of apoptosis and necroptosis by cFLIP

International Journal of Molecular Sciences

Volumn 16, Issue 12, 2015, Pages 30321-30341

  Tsuchiya, Yuichi ^a   Nakabayashi, Osamu ^a   Nakano, Hiroyasu ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Caspase 8; CFLIP; Necroptosis; TNF ; Ubiquitin proteasome system

Indexed keywords

BETA INTERFERON; CASPASE 3; CASPASE 8; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; FLICE INHIBITORY PROTEIN L; FLICE INHIBITORY PROTEIN R; FLICE INHIBITORY PROTEIN S; INHIBITOR OF APOPTOSIS PROTEIN; MIXED LINEAGE KINASE LIKE PROTEIN; PATTERN RECOGNITION RECEPTOR; PROCASPASE 8; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 7; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; PROTEASOME; UBIQUITIN;

APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; DOWN REGULATION; ENZYME INHIBITION; HUMAN; NECROPTOSIS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UBIQUITINATION; WESTERN BLOTTING; ANIMAL; HOMEOSTASIS; METABOLISM; NECROSIS;

ANIMALS; APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; HOMEOSTASIS; HUMANS; NECROSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN;

EID: 84950150216     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms161226232     Document Type: Review

References (135)

1. Galluzzi, L.; Bravo-San Pedro, J.M.; Vitale, I.; Aaronson, S.A.; Abrams, J.M.; Adam, D.; Alnemri, E.S.; Altucci, L.; Andrews, D.; Annicchiarico-Petruzzelli, M.; et al. Essential versus accessory aspects of cell death: Recommendations of the NCCD 2015. Cell Death Differ. 2015, 22, 58-73. [CrossRef] [PubMed].
2. Thome, M.; Schneider, P.; Hofmann, K.; Fickenscher, H.; Meinl, E.; Neipel, F.; Mattmann, C.; Burns, K.; Bodmer, J.L.; Schröter, M.; et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997, 386, 517-521. [CrossRef] [PubMed].
3. Irmler, M.; Thome, M.; Hahne, M.; Schneider, P.; Hofmann, K.; Steiner, V.; Bodmer, J.L.; Schröter, M.; Burns, K.; Mattmann, C.; et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997, 388, 190-195. [PubMed].
4. Shu, H.B.; Halpin, D.; Goeddel, D.V. Casper is a FADD-and caspase-related inducer of apoptosis. Immunity 1997, 6, 751-763. [CrossRef].
5. Hu, S.; Vincenz, C.; Ni, J.; Gentz, R.; Dixit, V.M. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1-and CD-95-induced apoptosis. J. Biol. Chem. 1997, 272, 17255-17257. [CrossRef] [PubMed].
6. Srinivasula, S.M.; Ahmad, M.; Ottilie, S.; Bullrich, F.; Banks, S.; Wang, Y.; Fernandes-Alnemri, T.; Croce, C.M.; Litwack, G.; Tomaselli, K.J.; et al. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J. Biol. Chem. 1997, 272, 18542-18545. [CrossRef] [PubMed].
7. Goltsev, Y.V.; Kovalenko, A.V.; Arnold, E.; Varfolomeev, E.E.; Brodianskii, V.M.; Wallach, D. CASH, a novel caspase homologue with death effector domains. J. Biol. Chem. 1997, 272, 19641-19644. [CrossRef] [PubMed].
8. Inohara, N.; Koseki, T.; Hu, Y.; Chen, S.; Núñez, G. CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. Proc. Natl. Acad. Sci. USA 1997, 94, 10717-10722. [CrossRef] [PubMed].
9. Han, D.K.; Chaudhary, P.M.; Wright, M.E.; Friedman, C.; Trask, B.J.; Riedel, R.T.; Baskin, D.G.; Schwartz, S.M.; Hood, L. MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death. Proc. Natl. Acad. Sci. USA 1997, 94, 11333-11338. [CrossRef] [PubMed].
10. Rasper, D.M.; Vaillancourt, J.P.; Hadano, S.; Houtzager, V.M.; Seiden, I.; Keen, S.L.; Tawa, P.; Xanthoudakis, S.; Nasir, J.; Martindale, D.; et al. Cell death attenuation by "Usurpin", a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ. 1998, 5, 271-288. [CrossRef] [PubMed].
11. Golks, A.; Brenner, D.; Fritsch, C.; Krammer, P.H.; Lavrik, I.N. c-FLIPR, a new regulator of death receptor-induced apoptosis. J. Biol. Chem. 2005, 280, 14507-14513. [CrossRef] [PubMed].
12. Ueffing, N.; Keil, E.; Freund, C.; Kühne, R.; Schulze-Osthoff, K.; Schmitz, I. Mutational analyses of c-FLIPR, the only murine short FLIP isoform, reveal requirements for DISC recruitment. Cell Death Differ. 2008, 15, 773-782. [CrossRef] [PubMed].
13. Ueffing, N.; Singh, K.K.; Christians, A.; Thorns, C.; Feller, A.C.; Nagl, F.; Fend, F.; Heikaus, S.; Marx, A.; Zotz, R.B.; et al. A single nucleotide polymorphism determines protein isoform production of the human c-FLIP protein. Blood 2009, 114, 572-579. [CrossRef] [PubMed].
14. Salvesen, G.S.; Walsh, C.M. Functions of caspase 8: The identified and the mysterious. Semin. Immunol. 2014, 26, 246-252. [CrossRef] [PubMed].
15. Nakano, H.; Piao, X.; Shindo, R.; Komazawa-Sakon, S. Cellular FLICE-Inhibitory protein regulates tissue homeostasis. Curr. Top. Microbiol. Immunol. 2015. [CrossRef].
16. Safa, A.R. Roles of c-FLIP in apoptosis, necroptosis, and autophagy. J. Carcinog. Mutagen. 2013, 6. [CrossRef] [PubMed].
17. Krueger, A.; Schmitz, I.; Baumann, S.; Krammer, P.H.; Kirchhoff, S. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J. Biol. Chem. 2001, 276, 20633-20640. [CrossRef] [PubMed].
18. Chang, D.W.; Xing, Z.; Pan, Y.; Algeciras-Schimnich, A.; Barnhart, B.C.; Yaish-Ohad, S.; Peter, M.E.; Yang, X. c-FLIPL is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 2002, 21, 3704-3714. [CrossRef] [PubMed].
19. Micheau, O.; Thome, M.; Schneider, P.; Holler, N.; Tschopp, J.; Nicholson, D.W.; Briand, C.; Grütter, M.G. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem. 2002, 277, 45162-45171. [CrossRef] [PubMed].
20. Boatright, K.M.; Deis, C.; Denault, J.B.; Sutherlin, D.P.; Salvesen, G.S. Activation of caspases-8 and-10 by FLIPL. Biochem. J. 2004, 382, 651-657. [CrossRef] [PubMed].
21. Pop, C.; Oberst, A.; Drag, M.; van Raam, B.J.; Riedl, S.J.; Green, D.R.; Salvesen, G.S. FLIPL induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity. Biochem. J. 2011, 433, 447-457. [CrossRef] [PubMed].
22. Yu, J.W.; Jeffrey, P.D.; Shi, Y. Mechanism of procaspase-8 activation by c-FLIPL. Proc. Natl. Acad. Sci. USA 2009, 106, 8169-8174. [CrossRef] [PubMed].
23. Dickens, L.S.; Boyd, R.S.; Jukes-Jones, R.; Hughes, M.A.; Robinson, G.L.; Fairall, L.; Schwabe, J.W.; Cain, K.; Macfarlane, M. A death effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly in mediating apoptotic cell death. Mol. Cell 2012, 47, 291-305. [CrossRef] [PubMed].
24. Schleich, K.; Warnken, U.; Fricker, N.; Oztürk, S.; Richter, P.; Kammerer, K.; Schnölzer, M.; Krammer, P.H.; Lavrik, I.N. Stoichiometry of the CD95 death-inducing signaling complex: Experimental and modeling evidence for a death effector domain chain model. Mol. Cell 2012, 47, 306-319. [CrossRef] [PubMed].
25. Siegel, R.M.; Martin, D.A.; Zheng, L.; Ng, S.Y.; Bertin, J.; Cohen, J.; Lenardo, M.J. Death-effector filaments: Novel cytoplasmic structures that recruit caspases and trigger apoptosis. J. Cell Biol. 1998, 141, 1243-1253. [CrossRef] [PubMed].
26. Majkut, J.; Sgobba, M.; Holohan, C.; Crawford, N.; Logan, A.E.; Kerr, E.; Higgins, C.A.; Redmond, K.L.; Riley, J.S.; Stasik, I.; et al. Differential affinity of FLIP and procaspase 8 for FADD's DED binding surfaces regulates DISC assembly. Nat. Commun. 2014, 5. [CrossRef] [PubMed].
27. Kallenberger, S.M.; Beaudouin, J.; Claus, J.; Fischer, C.; Sorger, P.K.; Legewie, S.; Eils, R. Intra-and interdimeric caspase-8 self-cleavage controls strength and timing of CD95-induced apoptosis. Sci. Signal. 2014, 7, ra23. [CrossRef] [PubMed].
28. Schleich, K.; Buchbinder, J.H.; Pietkiewicz, S.; Kähne, T.; Warnken, U.; Öztürk, S.; Schnölzer, M.; Naumann, M.; Krammer, P.H.; Lavrik, I.N. Molecular architecture of the DED chains at the DISC: Regulation of procaspase-8 activation by short DED proteins c-FLIP and procaspase-8 prodomain. Cell Death Differ. 2015. [CrossRef] [PubMed].
29. Varfolomeev, E.E.; Boldin, M.P.; Goncharov, T.M.; Wallach, D. A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APO1: Proteins binding to the death domains of the two receptors also bind to each other. J. Exp. Med. 1996, 183, 1271-1275. [CrossRef] [PubMed].
30. Hsu, H.; Huang, J.; Shu, H.-B.; Baichwal, V.; Goeddel, D.V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-a signaling complex. Immunity 1996, 4, 387-396. [CrossRef].
31. Weinlich, R.; Green, D.R. The two faces of receptor interacting protein kinase-1. Mol. Cell 2014, 56, 469-480. [CrossRef] [PubMed].
32. Tenev, T.; Bianchi, K.; Darding, M.; Broemer, M.; Langlais, C.; Wallberg, F.; Zachariou, A.; Lopez, J.; MacFarlane, M.; Cain, K.; et al. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol. Cell 2011, 43, 432-448. [CrossRef] [PubMed].
33. Feoktistova, M.; Geserick, P.; Kellert, B.; Dimitrova, D.P.; Langlais, C.; Hupe, M.; Cain, K.; MacFarlane, M.; Häcker, G.; Leverkus, M. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol. Cell 2011, 43, 449-463. [CrossRef] [PubMed].
34. Schilling, R.; Geserick, P.; Leverkus, M. Characterization of the ripoptosome and its components: Implications for anti-inflammatory and cancer therapy. Methods Enzymol. 2014, 545, 83-102. [PubMed].
35. Pasparakis, M.; Vandenabeele, P. Necroptosis and its role in inflammation. Nature 2015, 517, 311-320. [CrossRef] [PubMed].
36. He, S.; Wang, L.; Miao, L.; Wang, T.; Du, F.; Zhao, L.; Wang, X. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α. Cell 2009, 137, 1100-1111. [CrossRef] [PubMed].
37. Feoktistova, M.; Geserick, P.; Panayotova-Dimitrova, D.; Leverkus, M. Pick your poison: The ripoptosome, a cell death platform regulating apoptosis and necroptosis. Cell Cycle 2012, 11, 460-467. [CrossRef] [PubMed].
38. Mandal, P.; Berger, S.B.; Pillay, S.; Moriwaki, K.; Huang, C.; Guo, H.; Lich, J.D.; Finger, J.; Kasparcova, V.; Votta, B.; et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol. Cell 2014, 56, 481-495. [CrossRef] [PubMed].
39. Day, T.W.; Huang, S.; Safa, A.R. c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8, and caspase-9-dependent apoptosis in breast cancer cells. Biochem. Pharmacol. 2008, 76, 1694-1704. [CrossRef] [PubMed].
40. Estornes, Y.; Toscano, F.; Virard, F.; Jacquemin, G.; Pierrot, A.; Vanbervliet, B.; Bonnin, M.; Lalaoui, N.; Mercier-Gouy, P.; Pachéco, Y.; et al. dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8. Cell Death Differ. 2012, 19, 1482-1494. [CrossRef] [PubMed].
41. Bentele, M.; Lavrik, I.; Ulrich, M.; Stösser, S.; Heermann, D.W.; Kalthoff, H.; Krammer, P.H.; Eils, R. Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis. J. Cell Biol. 2004, 166, 839-851. [CrossRef] [PubMed].
42. Lavrik, I.N.; Golks, A.; Riess, D.; Bentele, M.; Eils, R.; Krammer, P.H. Analysis of CD95 threshold signaling: Triggering of CD95 (FAS/APO-1) at low concentrations primarily results in survival signaling. J. Biol. Chem. 2007, 282, 13664-13671. [CrossRef] [PubMed].
43. Lavrik, I.N. Systems biology of death receptor networks: Live and let die. Cell Death Dis. 2014, 5, e1259. [CrossRef] [PubMed].
44. Fricker, N.; Beaudouin, J.; Richter, P.; Eils, R.; Krammer, P.H.; Lavrik, I.N. Model-based dissection of CD95 signaling dynamics reveals both a pro-and antiapoptotic role of c-FLIPL. J. Cell Biol. 2010, 190, 377-389. [CrossRef] [PubMed].
45. Han, L.; Zhao, Y.; Jia, X. Mathematical modeling identified c-FLIP as an apoptotic switch in death receptor induced apoptosis. Apoptosis 2008, 13, 1198-1204. [CrossRef] [PubMed].
46. Neumann, L.; Pforr, C.; Beaudouin, J.; Pappa, A.; Fricker, N.; Krammer, P.H.; Lavrik, I.N.; Eils, R. Dynamics within the CD95 death-inducing signaling complex decide life and death of cells. Mol. Syst. Biol. 2010, 6, 352. [CrossRef] [PubMed].
47. Scaffidi, C.; Schmitz, I.; Krammer, P.H.; Peter, M.E. The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 1999, 274, 1541-1548. [CrossRef] [PubMed].
48. Toivonen, H.T.; Meinander, A.; Asaoka, T.; Westerlund, M.; Pettersson, F.; Mikhailov, A.; Eriksson, J.E.; Saxén, H. Modeling reveals that dynamic regulation of c-FLIP levels determines cell-to-cell distribution of CD95-mediated apoptosis. J. Biol. Chem. 2011, 286, 18375-18382. [CrossRef] [PubMed].
49. Roux, J.; Hafner, M.; Bandara, S.; Sims, J.J.; Hudson, H.; Chai, D.; Sorger, P.K. Fractional killing arises from cell-to-cell variability in overcoming a caspase activity threshold. Mol. Syst. Biol. 2015, 11, 803. [CrossRef] [PubMed].
50. Kundu, M.; Pathak, S.K.; Kumawat, K.; Basu, S.; Chatterjee, G.; Pathak, S.; Noguchi, T.; Takeda, K.; Ichijo, H.; Thien, C.B.; et al. A TNF-and c-Cbl-dependent FLIPS-degradation pathway and its function in Mycobacterium tuberculosis-induced macrophage apoptosis. Nat. Immunol. 2009, 10, 918-926. [CrossRef] [PubMed].
51. Zhang, L.; Gallagher, P.J. Mind bomb 1 regulation of cFLIP interactions. Am. J. Physiol. Cell Physiol. 2009, 297, C1275-C1283. [CrossRef] [PubMed].
52. Scudiero, I.; Zotti, T.; Ferravante, A.; Vessichelli, M.; Reale, C.; Masone, M.C.; Leonardi, A.; Vito, P.; Stilo, R. Tumor necrosis factor (TNF) receptor-associated factor 7 is required for TNFα-induced Jun NH2-terminal kinase activation and promotes cell death by regulating polyubiquitination and lysosomal degradation of c-FLIP protein. J. Biol. Chem. 2012, 287, 6053-6061. [CrossRef] [PubMed].
53. Wang, Q.; Sun,W.; Hao, X.; Li, T.; Su, L.; Liu, X. Down-regulation of cellular FLICE-inhibitory protein (Long Form) contributes to apoptosis induced by Hsp90 inhibition in human lung cancer cells. Cancer Cell Int. 2012, 12, 54. [CrossRef] [PubMed].
54. Chang, L.; Kamata, H.; Solinas, G.; Luo, J.L.; Maeda, S.; Venuprasad, K.; Liu, Y.C.; Karin, M. The E3 ubiquitin ligase itch couples JNK activation to TNFα-induced cell death by inducing c-FLIPL turnover. Cell 2006, 124, 601-613. [CrossRef] [PubMed].
55. Nakajima, A.; Komazawa-Sakon, S.; Takekawa, M.; Sasazuki, T.; Yeh, W.C.; Yagita, H.; Okumura, K.; Nakano, H. An antiapoptotic protein, c-FLIPL, directly binds to MKK7 and inhibits the JNK pathway. EMBO J. 2006, 25, 5549-5559. [CrossRef] [PubMed].
56. Nakajima, A.; Kojima, Y.; Nakayama, M.; Yagita, H.; Okumura, K.; Nakano, H. Downregulation of c-FLIP promotes caspase-dependent JNK activation and reactive oxygen species accumulation in tumor cells. Oncogene 2008, 27, 76-84. [CrossRef] [PubMed].
57. Murata, E.; Hashimoto, M.; Aoki, T. Interaction between cFLIP and Itch, a ubiquitin ligase, is obstructed in Trypanosoma. cruzi-infected human cells. Microbiol. Immunol. 2008, 52, 539-543. [CrossRef] [PubMed].
58. Demange, C.; Ferrand, N.; Prunier, C.; Bourgeade, M.F.; Atfi, A. A model of partnership co-opted by the homeodomain protein TGIF and the Itch/AIP4 ubiquitin ligase for effective execution of TNF-α cytotoxicity. Mol. Cell 2009, 36, 1073-1085. [CrossRef] [PubMed].
59. Panner, A.; Crane, C.A.; Weng, C.; Feletti, A.; Parsa, A.T.; Pieper, R.O. A novel PTEN-dependent link to ubiquitination controls FLIPS stability and TRAIL sensitivity in glioblastoma multiforme. Cancer Res. 2009, 69, 7911-7916. [CrossRef] [PubMed].
60. Panner, A.; Crane, C.A.; Weng, C.; Feletti, A.; Fang, S.; Parsa, A.T.; Pieper, R.O. Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme. Cancer Res. 2010, 70, 5046-5053. [CrossRef] [PubMed].
61. Zhao, L.; Yue, P.; Khuri, F.R.; Sun, S.Y. mTOR complex 2 is involved in regulation of Cbl-dependent c-FLIP degradation and sensitivity of TRAIL-induced apoptosis. Cancer Res. 2013, 73, 1946-1957. [CrossRef] [PubMed].
62. Zhang, G.; Liu, J.; Zhang, Y.; Qu, J.; Xu, L.; Zheng, H.; Liu, Y.; Qu, X. Cbl-b-dependent degradation of FLIPL is involved in ATO-induced autophagy in leukemic K562 and gastric cancer cells. FEBS Lett. 2012, 586, 3104-3110. [CrossRef] [PubMed].
63. Haimerl, F.; Erhardt, A.; Sass, G.; Tiegs, G. Down-regulation of the de-ubiquitinating enzyme ubiquitin-specific protease 2 contributes to tumor necrosis factor-α-induced hepatocyte survival. J. Biol. Chem. 2009, 284, 495-504. [CrossRef] [PubMed].
64. Abedini, M.R.; Muller, E.J.; Brun, J.; Bergeron, R.; Gray, D.A.; Tsang, B.K. Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells. Cancer Res. 2008, 68, 4511-4517. [CrossRef] [PubMed].
65. Abedini, M.R.; Muller, E.J.; Bergeron, R.; Gray, D.A.; Tsang, B.K. Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein. Oncogene 2010, 29, 11-25. [CrossRef] [PubMed].
66. Abedini, M.R.; Wang, P.W.; Huang, Y.F.; Cao, M.; Chou, C.Y.; Shieh, D.B.; Tsang, B.K. Cell fate regulation by gelsolin in human gynecologic cancers. Proc. Natl. Acad. Sci. USA 2014, 111, 14442-14447. [CrossRef] [PubMed].
67. Santini, S.; Stagni, V.; Giambruno, R.; Fianco, G.; Di Benedetto, A.; Mottolese, M.; Pellegrini, M.; Barilà, D. ATM kinase activity modulates ITCH E3-ubiquitin ligase activity. Oncogene 2014, 33, 1113-1123. [CrossRef] [PubMed].
68. Yang, F.; Tay, K.H.; Dong, L.; Thorne, R.F.; Jiang, C.C.; Yang, E.; Tseng, H.Y.; Liu, H.; Christopherson, R.; Hersey, P.; et al. Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIPL from degradation by the E3 ligase itch in human melanoma cells. Cell Death Differ. 2010, 17, 1354-1367. [CrossRef] [PubMed].
69. Shi, B.; Tran, T.; Sobkoviak, R.; Pope, R.M. Activation-induced degradation of FLIPL is mediated via the phosphatidylinositol 3-kinase/Akt signaling pathway in macrophages. J. Biol. Chem. 2009, 284, 14513-14523. [CrossRef] [PubMed].
70. Sánchez-Pérez, T.; Ortiz-Ferrón, G.; López-Rivas, A. Mitotic arrest and JNK-induced proteasomal degradation of FLIP and Mcl-1 are key events in the sensitization of breast tumor cells to TRAIL by antimicrotubule agents. Cell Death Differ. 2010, 17, 883-894. [CrossRef] [PubMed].
71. Sánchez-Pérez, T.; Medema, R.H.; López-Rivas, A. Delaying mitotic exit downregulates FLIP expression and strongly sensitizes tumor cells to TRAIL. Oncogene 2015, 34, 661-669. [CrossRef] [PubMed].
72. Yerbes, R.; López-Rivas, A. Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAIL. Investig. New Drugs 2012, 30, 541-547. [CrossRef] [PubMed].
73. Kaunisto, A.; Kochin, V.; Asaoka, T.; Mikhailov, A.; Poukkula, M.; Meinander, A.; Eriksson, J.E. PKC-mediated phosphorylation regulates c-FLIP ubiquitylation and stability. Cell Death Differ. 2009, 13, 1215-1226. [CrossRef] [PubMed].
74. Wilkie-Grantham, R.P.; Matsuzawa, S.; Reed, J.C. Novel phosphorylation and ubiquitination sites regulates reactive oxygen species-dependent degradation of anti-apoptotic c-FLIP protein. J. Biol. Chem. 2013, 288, 12777-12790. [CrossRef] [PubMed].
75. Chanvorachote, P.; Nimmannit, U.; Wang, L.; Stehlik, C.; Lu, B.; Azad, N.; Rojanasakul, Y. Nitric oxide negatively regulates Fas CD95-induced apoptosis through inhibition of ubiquitin-proteasome-mediated degradation of FLICE inhibitory protein. J. Biol. Chem. 2005, 280, 42044-42050. [CrossRef] [PubMed].
76. Tran, S.E.; Meinander, A.; Holmström, T.H.; Rivero-Müller, A.; Heiskanen, K.M.; Linnau, E.K.; Courtney, M.J.; Mosser, D.D.; Sistonen, L.; Eriksson, J.E. Heat stress downregulates FLIP and sensitizes cells to Fas receptor-mediated apoptosis. Cell Death Differ. 2003, 10, 1137-1147. [CrossRef] [PubMed].
77. Meinander, A.; Söderström, T.S.; Kaunisto, A.; Poukkula, M.; Sistonen, L.; Eriksson, J.E. Fever-like hyperthermia controls T Lymphocyte persistence by inducing degradation of cellular FLIPshort. J. Immunol. 2007, 178, 3944-3953. [CrossRef] [PubMed].
78. Song, X.; Kim, S.Y.; Zhou, Z.; Lagasse, E.; Kwon, Y.T.; Lee, Y.J. Hyperthermia enhances mapatumumab-induced apoptotic death through ubiquitin-mediated degradation of cellular FLIP(long) in human colon cancer cells. Cell Death Dis. 2013, 4, e577. [CrossRef] [PubMed].
79. Morlé, A.; Garrido, C.; Micheau, O. Hyperthermia restores apoptosis induced by death receptors through aggregation-induced c-FLIP cytosolic depletion. Cell Death Dis. 2015, 6, e1633. [CrossRef] [PubMed].
80. Ishioka, T.; Katayama, R.; Kikuchi, R.; Nishimoto, M.; Takada, S.; Takada, R.; Matsuzawa, S.; Reed, J.C.; Tsuruo, T.; Naito, M. Impairment of the ubiquitin-proteasome system by cellular FLIP. Genes Cells 2007, 12, 735-744. [CrossRef] [PubMed].
81. Brüning, A.; Jückstock, J. Misfolded proteins: From little villains to little helpers in the fight against cancer. Front. Oncol. 2015, 5, 47. [PubMed].
82. Yeh, W.C.; Itie, A.; Elia, A.J.; Ng, M.; Shu, H.B.; Wakeham, A.; Mirtsos, C.; Suzuki, N.; Bonnard, M.; Goeddel, D.V.; et al. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 2000, 12, 633-642. [CrossRef].
83. Shibata, N.; Ohoka, N.; Sugaki, Y.; Onodera, C.; Inoue, M.; Sakuraba, Y.; Takakura, D.; Hashii, N.; Kawasaki, N.; Gondo, Y.; et al. Degradation of stop codon read-through mutant proteins via the ubiquitin-proteasome system causes hereditary disorders. J. Biol. Chem. 2015, 190, 28428-28437. [CrossRef] [PubMed].
84. Dillon, C.P.; Oberst, A.; Weinlich, R.; Janke, L.J.; Kang, T.B.; Ben-Moshe, T.; Mak, T.W.; Wallach, D.; Green, D.R. Survival function of the FADD-CASPASE-8-cFLIPL complex. Cell Rep. 2012, 1, 401-407. [CrossRef] [PubMed].
85. Chau, H.;Wong, V.; Chen, N.J.; Huang, H.L.; Lin,W.J.; Mirtsos, C.; Elford, A.R.; Bonnard, M.;Wakeham, A.; You-Ten, A.I.; et al. Cellular FLICE-inhibitory protein is required for T cell survival and cycling. J. Exp. Med. 2005, 202, 405-413. [CrossRef] [PubMed].
86. Zhang, N.; He, Y.W. An essential role for c-FLIP in the efficient development of mature T lymphocytes. J. Exp. Med. 2005, 202, 395-404. [CrossRef] [PubMed].
87. Zhang, N.; Hopkins, K.; He, Y.W. c-FLIP protects mature T lymphocytes from TCR-mediated killing. J. Immunol. 2008, 181, 5368-5373. [CrossRef].
88. He, M.X.; He, Y.W. c-FLIP protects T lymphocytes from apoptosis in the intrinsic pathway. J. Immunol. 2015, 194, 3444-3451. [CrossRef] [PubMed].
89. Zhang, H.; Rosenberg, S.; Coffey, F.J.; He, Y.W.; Manser, T.; Hardy, R.R.; Zhang, J. A role for cFLIP in B cell proliferation and stress MAPK regulation. J. Immunol. 2009, 182, 207-215. [CrossRef] [PubMed].
90. Coffey, F.; Manser, T. Expression of cellular FLIP by B cells is required for their participation in an immune response. J. Immunol. 2010, 184, 4871-4879. [CrossRef] [PubMed].
91. Gordy, C.; Pua, H.; Sempowski, G.D.; He, Y.W. Regulation of steady-state neutrophil homeostasis by macrophages. Blood 2011, 117, 618-629. [CrossRef] [PubMed].
92. Huang, Q.Q.; Perlman, H.; Huang, Z.; Birkett, R.; Kan, L.; Agrawal, H.; Misharin, A.; Gurbuxani, S.; Crispino, J.D.; Pope, R.M. FLIP: A novel regulator of macrophage differentiation and granulocyte homeostasis. Blood 2010, 116, 4968-4977. [CrossRef] [PubMed].
93. Huang, Q.Q.; Perlman, H.; Birkett, R.; Doyle, R.; Fang, D.; Haines, G.K.; Robinson,W.; Datta, S.; Huang, Z.; Li, Q.Z.; et al. CD11c-mediated deletion of Flip promotes autoreactivity and inflammatory arthritis. Nat. Commun. 2015, 6, 7086. [CrossRef] [PubMed].
94. Wu, Y.J.; Wu, Y.H.; Mo, S.T.; Hsiao, H.W.; He, Y.W.; Lai, M.Z. Cellular FLIP inhibits myeloid cell activation by suppressing selective innate signaling. J. Immunol. 2015, 195, 2612-2623. [CrossRef] [PubMed].
95. Piao, X.; Komazawa-Sakon, S.; Nishina, T.; Koike, M.; Piao, J.H.; Ehlken, H.; Kurihara, H.; Hara, M.; van Rooijen, N.; Schütz, G.; et al. c-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis. Sci. Signal. 2012, 5, ra93. [CrossRef] [PubMed].
96. Schattenberg, J.M.; Zimmermann, T.; Wörns, M.; Sprinzl, M.F.; Kreft, A.; Kohl, T.; Nagel, M.; Siebler, J.; Schulze Bergkamen, H.; He, Y.W.; et al. Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo. J. Hepatol. 2011, 55, 1272-1280. [CrossRef] [PubMed].
97. Schattenberg, J.M.; Nagel, M.; Kim, Y.O.; Kohl, T.; Wörns, M.A.; Zimmermann, T.; Schad, A.; Longerich, T.; Schuppan, D.; He, Y.W.; et al. Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 303, G498-G506. [CrossRef] [PubMed].
98. Schattenberg, J.M.; Wörns, M.A.; Zimmermann, T.; He, Y.W.; Galle, P.R.; Schuchmann, M. The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytes. Free Radic. Biol. Med. 2012, 52, 1911-1917. [CrossRef] [PubMed].
99. Kohl, T.; Gehrke, N.; Schad, A.; Nagel, M.; Wörns, M.A.; Sprinzl, M.F.; Zimmermann, T.; He, Y.W.; Galle, P.R.; Schuchmann, M.; et al. Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cells. Cell Death Dis. 2013, 4, e712. [CrossRef] [PubMed].
100. Gehrke, N.; Garcia-Bardon, D.; Mann, A.; Schad, A.; Alt, Y.; Wörns, M.A.; Sprinzl, M.F.; Zimmermann, T.; Menke, J.; Engstler, A.J.; et al. Acute organ failure following the loss of anti-apoptotic cellular FLICE-inhibitory protein involves activation of innate immune receptors. Cell Death Differ. 2015, 22, 826-837. [CrossRef] [PubMed].
101. Wittkopf, N.; Günther, C.; Martini, E.; He, G.; Amann, K.; He, Y.W.; Schuchmann, M.; Neurath, M.F.; Becker, C. Cellular FLICE-like inhibitory protein secures intestinal epithelial cell survival and immune homeostasis by regulating caspase-8. Gastroenterology 2013, 145, 1369-1379. [CrossRef] [PubMed].
102. Weinlich, R.; Oberst, A.; Dillon, C.P.; Janke, L.J.; Milasta, S.; Lukens, J.R.; Rodriguez, D.A.; Gurung, P.; Savage, C.; Kanneganti, T.D.; et al. Protective roles for caspase-8 and cFLIP in adult homeostasis. Cell Rep. 2013, 5, 340-348. [CrossRef] [PubMed].
103. Panayotova-Dimitrova, D.; Feoktistova, M.; Ploesser, M.; Kellert, B.; Hupe, M.; Horn, S.; Makarov, R.; Jensen, F.; Porubsky, S.; Schmieder, A.; et al. cFLIP regulates skin homeostasis and protects against TNF-induced keratinocyte apoptosis. Cell Rep. 2013, 5, 397-408. [CrossRef] [PubMed].
104. Zhang, N.; Hopkins, K.; He, Y.W. The long isoform of cellular FLIP is essential for T lymphocyte proliferation through an NF-kB-independent pathway. J. Immunol. 2008, 180, 5506-5511. [CrossRef] [PubMed].
105. He, M.X.; He, Y.W. A role for c-FLIPL in the regulation of apoptosis, autophagy, and necroptosis in T lymphocytes. Cell Death Differ. 2013, 20, 188-197. [CrossRef] [PubMed].
106. Lens, S.M.; Kataoka, T.; Fortner, K.A.; Tinel, A.; Ferrero, I.; MacDonald, R.H.; Hahne, M.; Beermann, F.; Attinger, A.; Orbea, H.A.; et al. The caspase 8 inhibitor c-FLIPL modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Mol. Cell. Biol. 2002, 22, 5419-5433. [CrossRef] [PubMed].
107. Tai, T.S.; Fang, L.W.; Lai, M.Z. c-FLICE inhibitory protein expression inhibits T-cell activation. Cell. Death Differ. 2004, 11, 69-79. [CrossRef] [PubMed].
108. Dohrman, A.; Kataoka, T.; Cuenin, S.; Russell, J.Q.; Tschopp, J.; Budd, R.C. Cellular FLIP (long form) regulates CD8+ T cell activation through caspase-8-dependent NF-kB activation. J. Immunol. 2005, 174, 5270-5278. [CrossRef] [PubMed].
109. Dohrman, A.; Russell, J.Q.; Cuenin, S.; Fortner, K.; Tschopp, J.; Budd, R.C. Cellular FLIP long form augments caspase activity and death of T cells through heterodimerization with and activation of caspase-8. J. Immunol. 2005, 175, 311-318. [CrossRef] [PubMed].
110. Wu, W.; Rinaldi, L.; Fortner, K.A.; Russell, J.Q.; Tschopp, J.; Irvin, C.; Budd, R.C. Cellular FLIP long form-transgenic mice manifest a Th2 cytokine bias and enhanced allergic airway inflammation. J. Immunol. 2004, 172, 4724-4732. [CrossRef] [PubMed].
111. Tseveleki, V.; Bauer, J.; Taoufik, E.; Ruan, C.; Leondiadis, L.; Haralambous, S.; Lassmann, H.; Probert, L. Cellular FLIP (long isoform) overexpression in T cells drives Th2 effector responses and promotes immunoregulation in experimental autoimmune encephalomyelitis. J. Immunol. 2004, 173, 6619-6626. [CrossRef] [PubMed].
112. Tseveleki, V.; Tsagozis, P.; Koutsoni, O.; Dotsika, E.; Probert, L. Cellular FLIP long isoform transgenic mice overcome inherent Th2-biased immune responses to efficiently resolve Leishmania. major infection. Int. Immunol. 2007, 19, 1183-1189. [CrossRef] [PubMed].
113. Huber, S.; Dohrman, A.; Sartini, D.; Budd, R.C. Reduced myocarditis following Coxsackievirus infection in cellular FLICE inhibitory protein-Long form-transgenic mice. Immunology 2006, 119, 541-550. [CrossRef] [PubMed].
114. Qiao, G.; Li, Z.; Minto, A.W.; Shia, J.; Yang, L.; Bao, L.; Tschopp, J.; Gao, J.X.; Wang, J.; Quigg, R.J.; et al. Altered thymic selection by overexpressing cellular FLICE inhibitory protein in T cells causes lupus-like syndrome in a BALB/c but not C57BL/6 strain. Cell Death Differ. 2010, 17, 522-533. [CrossRef] [PubMed].
115. Fang, Y.; Sharp, G.C.; Braley-Mullen, H. Effect of transgenic overexpression of FLIP on lymphocytes on development and resolution of experimental autoimmune thyroiditis. Am. J. Pathol. 2011, 179, 1211-1220. [CrossRef] [PubMed].
116. Oehme, I.; Neumann, F.; Bösser, S.; Zörnig, M. Transgenic overexpression of the Caspase-8 inhibitor FLIPshort leads to impaired T cell proliferation and an increased memory T cell pool after Staphylococcal enterotoxin B injection. Eur. J. Immunol. 2005, 35, 1240-1249. [CrossRef] [PubMed].
117. Buskiewicz, I.A.; Koenig, A.; Roberts, B.; Russell, J.; Shi, C.; Lee, S.H.; Jung, J.U.; Huber, S.A.; Budd, R.C. c-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3. PLoS ONE 2014, 9, e96156. [CrossRef] [PubMed].
118. Taoufik, E.; Valable, S.; Müller, G.J.; Roberts, M.L.; Divoux, D.; Tinel, A.; Voulgari-Kokota, A.; Tseveleki, V.; Altruda, F.; Lassmann, H.; et al. FLIPL protects neurons against in vivo ischemia and in vitro glucose deprivation-induced cell death. J. Neurosci. 2007, 27, 6633-6646. [CrossRef] [PubMed].
119. Fang, Y.; Braley-Mullen, H. Cultured murine thyroid epithelial cells expressing transgenic Fas-associated death domain-like interleukin-1β converting enzyme inhibitory protein are protected from Fas-mediated apoptosis. Endocrinology 2008, 149, 3321-3329. [CrossRef] [PubMed].
120. Wang, S.H.; Arscott, P.; Wu, P.; Baker, J.R., Jr. No apparent damage in the thyroid of transgenic mice expressing antiapoptotic FLIP. Thyroid 2006, 16, 1-8. [CrossRef] [PubMed].
121. Fang, Y.; Wei, Y.; Demarco, V.; Chen, K.; Sharp, G.C.; Braley-Mullen, H. Murine FLIP transgene expressed on thyroid epithelial cells promotes resolution of granulomatous experimental autoimmune thyroiditis in DBA/1 mice. Am. J. Pathol. 2007, 170, 875-887. [CrossRef] [PubMed].
122. Fang, Y.; DeMarco, V.G.; Sharp, G.C.; Braley-Mullen, H. Expression of transgenic FLIP on thyroid epithelial cells inhibits induction and promotes resolution of granulomatous experimental autoimmune thyroiditis in CBA/J mice. Endocrinology 2007, 148, 5734-5745. [CrossRef] [PubMed].
123. Li, H.; Tang, Q.Z.; Liu, C.; Moon, M.; Chen, M.; Yan, L.; Bian, Z.Y.; Zhang, Y.; Wang, A.B.; Nghiem, M.P.; et al. Cellular FLICE-inhibitory protein protects against cardiac remodeling induced by angiotensin II in mice. Hypertension 2010, 56, 1109-1117. [CrossRef] [PubMed].
124. Xiao, J.; Moon, M.; Yan, L.; Nian, M.; Zhang, Y.; Liu, C.; Lu, J.; Guan, H.; Chen, M.; Jiang, D.; et al. Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction. Basic Res. Cardiol. 2012, 107, 239. [CrossRef] [PubMed].
125. Gordy, C.; Liang, J.; Pua, H.; He, Y.W. c-FLIP protects eosinophils from TNF-α-mediated cell death in vivo. PLoS ONE 2014, 9, e107724. [CrossRef] [PubMed].
126. Antonangeli, F.; Petrungaro, S.; Coluccia, P.; Filippini, A.; Ziparo, E.; Giampietri, C. Testis atrophy and reduced sperm motility in transgenic mice overexpressing c-FLIPL. Fertil. Steril. 2010, 93, 1407-1414. [CrossRef] [PubMed].
127. Giampietri, C.; Petrungaro, S.; Musumeci, M.; Coluccia, P.; Antonangeli, F.; De Cesaris, P.; Filippini, A.; Marano, G.; Ziparo, E. c-Flip overexpression reduces cardiac hypertrophy in response to pressure overload. J. Hypertens. 2008, 26, 1008-1016. [CrossRef] [PubMed].
128. Giampietri, C.; Petrungaro, S.; Coluccia, P.; Antonangeli, F.; Giannakakis, K.; Faraggiana, T.; Filippini, A.; Cossu, G.; Ziparo, E. c-Flip overexpression affects satellite cell proliferation and promotes skeletal muscle aging. Cell Death Dis. 2010, 1, e38. [CrossRef] [PubMed].
129. Telieps, T.; Ewald, F.; Gereke, M.; Annemann, M.; Rauter, Y.; Schuster, M.; Ueffing, N.; von Smolinski, D.; Gruber, A.D.; Bruder, D.; et al. Cellular-FLIP, Raji isoform (c-FLIPR) modulates cell death induction upon T-cell activation and infection. Eur. J. Immunol. 2013, 43, 1499-1510. [CrossRef] [PubMed].
130. Ewald, F.; Annemann, M.; Pils, M.C.; Plaza-Sirvent, C.; Neff, F.; Erck, C.; Reinhold, D.; Schmitz, I. Constitutive expression of murine c-FLIPR causes autoimmunity in aged mice. Cell Death Dis. 2014, 5, e1168. [CrossRef] [PubMed].
131. Oberst, A.; Dillon, C.P.; Weinlich, R.; McCormick, L.L.; Fitzgerald, P.; Pop, C.; Hakem, R.; Salvesen, G.S.; Green, D.R. Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis. Nature 2011, 471, 363-367. [CrossRef] [PubMed].
132. Antonangeli, F.; Giampietri, C.; Petrungaro, S.; Filippini, A.; Ziparo, E. Expression profile of a 400-bp Stra8 promoter region during spermatogenesis. Microsc. Res. Tech. 2009, 72, 816-822. [CrossRef] [PubMed].
133. Chauhan, L.; Jenkins, G.D.; Bhise, N.; Feldberg, T.; Mitra-Ghosh, T.; Fridley, B.L.; Lamba, J.K. Genome-wide association analysis identified splicing single nucleotide polymorphism in CFLAR predictive of triptolide chemo-sensitivity. BMC Genom. 2015, 16, 483. [CrossRef] [PubMed].
134. Safa, A.R.; Pollok, K.E. Targeting the Anti-apoptotic protein c-FLIP for cancer therapy. Cancers 2011, 2, 1639-1671. [CrossRef] [PubMed].
135. Urbano, P.C.; Soccol, V.T.; Azevedo, V.F. Apoptosis and the FLIP and NF-kB proteins as pharmacodynamic criteria for biosimilar TNF-α antagonists. Biologics 2014, 8, 211-220. [PubMed].